Reports for APOTEX INC
Company Name APOTEX INC |
||
|---|---|---|
Totals |
||
Shortage reports |
3367 |
|
| Actual shortage: | 219 (7%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 3138 (93%) | |
Discontinuation Reports |
365 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 341 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
144 (4%) |
|
Overdue reports |
68 (28%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-FINGOLIMOD | 0.5MG | CAPSULE | Actual shortage | 2024-01-19 | 2024-05-10 | 216744 |
| APO-FLAVOXATE | 200MG | TABLET | Actual shortage | 2017-08-14 | 2017-10-05 | 19117 |
| APO-FLECAINIDE | 100MG | TABLET | Resolved | 2019-10-23 | 2019-11-04 | 97048 |
| APO-FLECAINIDE | 50MG | TABLET | Resolved | 2019-10-23 | 2019-11-04 | 97051 |
| APO-FLECAINIDE | 50MG | TABLET | Resolved | 2022-06-27 | 2022-09-06 | 163445 |
| APO-FLECAINIDE | 100MG | TABLET | Resolved | 2022-08-12 | 2022-09-02 | 166607 |
| APO-FLECAINIDE | 50MG | TABLET | Resolved | 2021-01-08 | 2021-01-20 | 131160 |
| APO-FLECAINIDE | 50MG | TABLET | Resolved | 2024-01-05 | 2024-02-16 | 215218 |
| APO-FLECAINIDE | 50MG | TABLET | Resolved | 2022-12-23 | 2023-01-13 | 179450 |
| APO-FLECAINIDE | 100MG | TABLET | Resolved | 2024-10-31 | 2024-12-13 | 241691 |
| APO-FLECAINIDE | 50MG | TABLET | Resolved | 2024-11-29 | 2024-12-13 | 244200 |
| APO-FLECAINIDE | 50MG | TABLET | Resolved | 2023-09-01 | 2023-09-07 | 203539 |
| APO-FLUCONAZOLE | Resolved | 2018-01-18 | 2018-05-04 | 36496 | ||
| APO-FLUCONAZOLE | 50MG | TABLET TABLET | Resolved | 2025-04-24 | 2025-05-02 | 255669 |
| APO-FLUCONAZOLE | 50MG | TABLET TABLET | Resolved | 2020-11-26 | 2021-02-09 | 128928 |
| APO-FLUCONAZOLE | 100MG | TABLET TABLET | Resolved | 2020-12-04 | 2021-02-09 | 129601 |
| APO-FLUCONAZOLE | 100MG | TABLET TABLET | Resolved | 2021-11-12 | 2022-01-24 | 149160 |
| APO-FLUCONAZOLE-150 | 150MG | CAPSULE CAPSULE | Resolved | 2021-05-25 | 2021-09-20 | 139837 |
| APO-FLUCONAZOLE-150 | 150MG | CAPSULE | Resolved | 2019-03-05 | 2019-04-26 | 77884 |
| APO-FLUCONAZOLE-150 | 150MG | CAPSULE CAPSULE | Resolved | 2024-11-21 | 2025-02-28 | 243626 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-BISACODYL | 5MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-09-07 | 2018-09-15 | 60288 |
| APO-BOSENTAN | 62.5MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71339 |
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71342 |
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2018-09-07 | 2018-10-31 | 60291 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2018-09-07 | 2018-12-28 | 60301 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2020-11-16 | 2020-11-16 | 128438 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | To be discontinued | 2018-09-07 | 2018-09-07 | 60294 |
| APO-BROMAZEPAM - TAB 1.5MG | 1.5MG | TABLET | To be discontinued | 2018-09-07 | 2018-09-07 | 60304 |
| APO-BROMAZEPAM - TAB 3MG | 3MG | TABLET | Discontinued | 2018-09-07 | 2019-06-12 | 60307 |
| APO-BROMAZEPAM - TAB 6MG | 6MG | TABLET | Discontinued | 2018-09-07 | 2018-10-19 | 60310 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60313 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60316 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60325 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60322 |
| APO-CANDESARTAN | 4MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60319 |
| APO-CANDESARTAN | 32MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60328 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60335 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60331 |
| APO-CANDESARTAN/HCTZ | 25MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-05-03 | 41011 |
| APO-CANDESARTAN/HCTZ | 12.5MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41020 |